The paper “ Assessing cost-effectiveness of early intervention in Alzheimer’s disease: An open-source modeling framework”, co-authored by Quantify’s Anders Gustavsson has been published in Alzheimer’s & Dementia.

This paper presents the development of an anticipated open-source model which can be used to evaluate disease modifying treatment in Alzheimer’s disease. The model was developed by researchers in a work group affiliated to the International Pharmaco-Economic Collaboration on Alzheimer’s Disease (IPECAD). A copy of the model can be requested at their website IPECAD.org.